Repligen
Repligen (Nasdaq:RGEN) is a biopharmaceutical company focused on the development of novel therapeutics for the treatment of diseases of the central nervous system.
What is Foolsaurus?
It's a glossary of investing terms edited and maintained by our analysts, writers and YOU, our Foolish community. Get Started Now!
RSS Headlines
Fool UK- Fool Friends:
- Yahoo Finance
- MSN Money
- AOL Business News
- Mint Personal Finance Software
- lovemoney.com
- Copyright, Trademark and Patent Information
- Terms of Use © 1995 - The Motley Fool. All rights reserved.
BATS data provided in real-time. NYSE, NASDAQ and NYSEMKT data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar. Earnings Estimates and Analyst Ratings provided by Zacks.
SEC Filings and Insider Transactions provided by Edgar Online.
Powered and implemented by Interactive Data Managed Solutions. Terms & Conditions
lnwikiweb01.foolhq.com